17-alpha-hydroxyprogesterone and Premature Rupture of Fetal Membranes

17-alpha-hydroxyprogesterone has been researched along with Premature Rupture of Fetal Membranes in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Biron-Shental, T; Cohen, G; Miller, N; Moran, R; Ovadia, M; Schreiber, H; Shavit, M; Shechter-Maor, G; Weitzner, O; Yagur, Y	1
Kumar, D; Lockwood, CJ; Mansour, JM; Mercer, BM; Mesiano, S; Moore, JJ; Moore, RM; Philipson, E; Schatz, F; Springel, E	1
Briery, CM; Chauhan, SP; Klauser, CK; Magann, EF; Martin, RW; Morrison, JC; Veillon, EW	1

Trials

1 trial(s) available for 17-alpha-hydroxyprogesterone and Premature Rupture of Fetal Membranes

Article	Year
Women with preterm premature rupture of the membranes do not benefit from weekly progesterone. American journal of obstetrics and gynecology, 2011, Volume: 204, Issue:1 Topics: 17-alpha-Hydroxyprogesterone; Adult; Algorithms; Drug Administration Schedule; Female; Fetal Membranes, Premature Rupture; Fetal Mortality; Gestational Age; Humans; Labor Stage, First; Mississippi; Pregnancy; Premature Birth; Statistics, Nonparametric; Young Adult	2011

Article

Year

Women with preterm premature rupture of the membranes do not benefit from weekly progesterone.

American journal of obstetrics and gynecology, 2011, Volume: 204, Issue:1

Topics: 17-alpha-Hydroxyprogesterone; Adult; Algorithms; Drug Administration Schedule; Female; Fetal Membranes, Premature Rupture; Fetal Mortality; Gestational Age; Humans; Labor Stage, First; Mississippi; Pregnancy; Premature Birth; Statistics, Nonparametric; Young Adult

2011

Other Studies

2 other study(ies) available for 17-alpha-hydroxyprogesterone and Premature Rupture of Fetal Membranes

Article	Year
Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM? PloS one, 2022, Volume: 17, Issue:5 Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Premature Birth; Retrospective Studies	2022
Progesterone inhibits in vitro fetal membrane weakening. American journal of obstetrics and gynecology, 2015, Volume: 213, Issue:4 Topics: 17-alpha-Hydroxyprogesterone; Chorion; Decidua; Extraembryonic Membranes; Female; Fetal Membranes, Premature Rupture; Granulocyte-Macrophage Colony-Stimulating Factor; Hemostatics; Humans; In Vitro Techniques; Medroxyprogesterone Acetate; Pregnancy; Progesterone; Progestins; Thrombin; Tumor Necrosis Factor-alpha	2015

Article

Year

Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM?

PloS one, 2022, Volume: 17, Issue:5

Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Premature Birth; Retrospective Studies

2022

Progesterone inhibits in vitro fetal membrane weakening.

American journal of obstetrics and gynecology, 2015, Volume: 213, Issue:4

Topics: 17-alpha-Hydroxyprogesterone; Chorion; Decidua; Extraembryonic Membranes; Female; Fetal Membranes, Premature Rupture; Granulocyte-Macrophage Colony-Stimulating Factor; Hemostatics; Humans; In Vitro Techniques; Medroxyprogesterone Acetate; Pregnancy; Progesterone; Progestins; Thrombin; Tumor Necrosis Factor-alpha

2015